Novavax Inc
(WBO:NVAX)
€
9.276
-0.09 (-0.96%)
Market Cap: 1.49 Bil
Enterprise Value: 734.28 Mil
PE Ratio: 0
PB Ratio: 0
GF Score: 47/100 Novavax Inc at Jefferies London Healthcare Conference Transcript
Nov 15, 2023 / 09:00AM GMT
Roger Song
Jefferies LLC, Research Division - Equity Associate
Welcome to Day 2 at Jefferies Healthcare Conference in London. My name is Roger Song, one of the senior analysts who covers Biotech at Jefferies in the U.S. Next presenting company is Novavax. Welcome, John, Filip, and Jim.
John Charles Jacobs
Novavax, Inc. - President, CEO & Director
Thank you, Roger.
Filip Dubovsky
Novavax, Inc. - President of Research & Development
Hey, Roger.
James Patrick Kelly
Novavax, Inc. - Executive VP, CFO & Treasurer
Thanks, Roger.
Questions & Answers
Roger Song;John Charles
Jefferies LLC, Research Division - Equity Associate
Awesome. So maybe we kick this off right now. So maybe, John, as a relatively new CEO, but you have been with Novavax for a couple of months already, what is your updated elevator pitch for Novavax with the recent kind of a strategic priority you lay out for the company?
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot